As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...